Evidence map›Paper›PMID 24922578›Full record

ArticleCell host & microbe2014

Porphyromonas gingivalis manipulates complement and TLR signaling to uncouple bacterial clearance from inflammation and promote dysbiosis.

Tomoki Maekawa, Jennifer L Krauss, Toshiharu Abe, Ravi Jotwani, Martha Triantafilou, Kathy Triantafilou, Ahmed Hashim, Shifra Hoch, Michael A Curtis, Gabriel Nussbaum and 2 more

Open access · bronzeAbstract read
In one paragraph

Article in Cell host & microbe, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 271 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
271citing papers in PubMed, 1 pooled it
27.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

271 citing papers in PubMed, 1 synthesis or guideline pooled it, 410 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Review
  6. Article
  7. Article
  8. Article
  9. Infection and immunity · 2026
    Article
  10. Review
  11. Infection and immunity · 2026
    Article
  12. Review
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

211 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 3 countries.

Tomoki MaekawaUniversity of Pennsylvania, School of Dental Medicine, Department of Microbiology, Philadelphia, PA 19104, USA.
Jennifer L KraussUniversity of Louisville, Center for Oral Health and Systemic Disease, Louisville, KY 40292, USA.
Toshiharu AbeUniversity of Pennsylvania, School of Dental Medicine, Department of Microbiology, Philadelphia, PA 19104, USA.
Ravi JotwaniUniversity of Louisville, Center for Oral Health and Systemic Disease, Louisville, KY 40292, USA.
Martha TriantafilouCardiff University School of Medicine, Institute of Infection and Immunity, Cardiff CF14 4XN, UK.
Kathy TriantafilouCardiff University School of Medicine, Institute of Infection and Immunity, Cardiff CF14 4XN, UK.
Ahmed HashimQueen Mary University of London, Centre for Immunology and Infectious Disease, Blizard Institute, Barts and The London School of Medicine and Dentistry, London E1 2AT, UK.
Shifra HochHebrew University, Hadassah Dental School, Jerusalem 12272, Israel.
Michael A CurtisQueen Mary University of London, Centre for Immunology and Infectious Disease, Blizard Institute, Barts and The London School of Medicine and Dentistry, London E1 2AT, UK.
Gabriel NussbaumHebrew University, Hadassah Dental School, Jerusalem 12272, Israel.
John D LambrisUniversity of Pennsylvania, Perelman School of Medicine, Department of Pathology and Laboratory Medicine, Philadelphia, PA 19104, USA.
George HajishengallisUniversity of Pennsylvania, School of Dental Medicine, Department of Microbiology, Philadelphia, PA 19104, USA. Electronic address: geoh@upenn.edu.
University of Pennsylvania · USCardiff University · GBHebrew University of Jerusalem · ILQueen Mary University of London · GBUniversity of Louisville · US

Funding

Role of complement in kidney disorders: from hemodialysis to transportationP01AI068730 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI LAMBRIS, JOHN D · 2007 to 2018
$16.0M
P. gingivalis as a keystone pathogenR01DE015254 · NIDCR · UNIVERSITY OF PENNSYLVANIA · PI HAJISHENGALLIS, GEORGIOS · 2004 to 2018
$4.6M
Novel mechanisms and 'complement-ary' therapy in periodontitisR01DE021685 · NIDCR · UNIVERSITY OF PENNSYLVANIA · PI HAJISHENGALLIS, GEORGIOS · 2012 to 2016
$2.0M
Medical Research Council G0900408Medical Research Council MR/J011118/1NIAID NIH HHS AI068730NIAID NIH HHS P01 AI068730NIDCR NIH HHS DE015254NIDCR NIH HHS DE021685NIDCR NIH HHS R01 DE015254NIDCR NIH HHS R01 DE021685
6 · The paper itself

Abstract

Certain low-abundance bacterial species, such as the periodontitis-associated oral bacterium Porphyromonas gingivalis, can subvert host immunity to remodel a normally symbiotic microbiota into a dysbiotic, disease-provoking state. However, such pathogens also exploit inflammation to thrive in dysbiotic conditions. How these bacteria evade immunity while maintaining inflammation is unclear. As previously reported, P. gingivalis remodels the oral microbiota into a dysbiotic state by exploiting complement. Now we show that in neutrophils P. gingivalis disarms a host-protective TLR2-MyD88 pathway via proteasomal degradation of MyD88, whereas it activates an alternate TLR2-Mal-PI3K pathway. This alternate TLR2-Mal-PI3K pathway blocks phagocytosis, provides "bystander" protection to otherwise susceptible bacteria, and promotes dysbiotic inflammation in vivo. This mechanism to disengage bacterial clearance from inflammation required an intimate crosstalk between TLR2 and the complement receptor C5aR and can contribute to the persistence of microbial communities that drive dysbiotic diseases.

Indexed as

AnimalsBacteroidaceae InfectionsComplement System ProteinsDysbiosisHost-Pathogen InteractionsMiceMice, Mutant StrainsMyeloid Differentiation Factor 88NeutrophilsPeriodontitisPhagocytosisPhosphatidylinositol 3-KinasesPorphyromonas gingivalisReceptor, Anaphylatoxin C5aSignal TransductionToll-Like Receptor 2C5AR1 protein, humanComplement System ProteinsMyd88 protein, mouseMyeloid Differentiation Factor 88Phosphatidylinositol 3-KinasesReceptor, Anaphylatoxin C5aTLR2 protein, humanTlr2 protein, mouseToll-Like Receptor 2

Identifiers

PMID24922578
PMCPMC4071223
OpenAlexW2146766390

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.